Physician profile
Mit P Dave
NPI 1679816987
$1,104.81
in general payments reported to CMS, 2019-2025
13 companies · $162 in 2025
The $162 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $131 · 2020: $243 · 2021: $31.02 · 2022: $180 · 2024: $358 · 2025: $162.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $519.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $519.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $357.49 | 2021-2025 | Penditure, Mosaic, Avalus |
| Biotronik INC. | $143.01 | 2020 | |
| Abbvie INC. | $133.93 | 2024 | |
| Novo Nordisk INC | $126.47 | 2024-2025 | Ozempic, Rybelsus, Wegovy |
| Amarin Pharma, INC. | $114.74 | 2019 | |
| Medtronic Vascular, INC. | $100.18 | 2020 | |
| Ironshore Pharmaceuticals INC. | $26.43 | 2024 | |
| Lundbeck LLC | $20.86 | 2024 | Rexulti |
| Aimmune Therapeutics, INC. | $18.73 | 2024 | |
| Lilly USA, LLC | $16.61 | 2024 | Zepbound, Mounjaro |
| E.R. Squibb & Sons, L.L.C. | $16.22 | 2019 | |
| Dexcom, INC. | $15.68 | 2025 | Dexcom G6 Transmitter |
| Exact Sciences Corporation | $14.46 | 2025 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mit Dave listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.